U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07823959) titled 'CBC-Based Inflammatory Indices in Newly Diagnosed Multiple Myeloma' on Sept. 11.
Brief Summary: Multiple myeloma is a type of blood cancer characterized by the abnormal growth of plasma cells in the bone marrow. Increasing evidence indicates that interactions between myeloma cells and the host immune-inflammatory response influence disease behavior and patient outcomes. Inflammatory markers calculated from routine complete blood count (CBC) tests, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), offer simple, inexpensive ways to assess systemic inflammatio...